The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Share News (NSCI)

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 62.50
Bid: 60.00
Ask: 65.00
Change: -0.50 (-0.79%)
Spread: 5.00 (8.333%)
Open: 63.00
High: 63.00
Low: 62.50
Prev. Close: 63.00
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Foxtons Seeks Placing To Avoid Crisis

Fri, 17th Apr 2020 11:19

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.

----------

FTSE 100 - WINNERS

----------

Flutter Entertainment, up 11%. The gambling firm reported a rise in revenue in its most recently ended quarter before betting shops were closed and sports events cancelled to combat the spread of Covid-19. For the three months to the end of March, the FTSE 100 gambling firm saw revenue rise 16% year-on-year to GBP547 million from GBP478 million. Flutter said performance has deteriorated significantly since the introduction of restrictions on movement to fight the spread of Covid-19 but not as badly was first feared. In the four weeks from March 16 to April 12, revenue for PBB Online fell by 32% year-on-year. Sports revenue declined by 57% and by 65% since the suspension of Irish racing from March 25. However, Gaming revenue increased by 15%.

----------

Rio Tinto, up 5.0%. The miner saw a "robust" production performance in the first quarter, with iron ore output up on a year ago. For the first three months of 2020, Pilbara iron ore production rose 2% on a year before to 77.8 million tonnes, with shipments up 5% at 72.9 million. Bauxite production was up 8% at 13.8 million tonnes. However, aluminium production fell 2% to 783,000 tonnes and mined copper was down 8% at 133,000 tonnes in the quarter. Titanium dioxide slag output was down 1% to 293,000 tonnes, while the production of pellets and concentrate at the Iron Ore Co of Canada rose 3% to 2.6 million tonnes. For 2020, Rio Tinto now expects capital expenditure to be around USD5 billion to USD6 billion, down from previous guidance of USD7 billion. The miner largely held its production guidance for the year, though copper was nudged down to between 475,000 tonnes to 520,000 tonnes, from a range of 530,000 tonnes to 570,000 tonnes previously. Titanium dioxide slag is now guided to be at the lower end of the firm's previous 1.2 million to 1.4 million tonne range.

----------

FTSE 250 - WINNERS

----------

Brewin Dolphin, up 12%. The asset manager reported a sharp drop in funds under management during the first half, but was able to secure net inflows in an "encouraging" performance. At March 31, funds under management stood at GBP41.4 billion, down 15% from GBP48.5 billion at the end of 2019, and 8.0% lower than the GBP45.0 billion seen at the end of September. In the first half, Brewin recorded GBP600 million in net inflows, but this was more than offset by market movements, slicing GBP6.9 billion off total funds. Most of this damage occurred in the second quarter, as the Covid-19 pandemic disrupted global financial markets. The three months to March 31, market performance lopped GBP7.5 billion off total funds. More promisingly, however, Brewin was able to record GBP400 million in net inflows in the period - which represents 3.8% year on year growth. Brewin's total income in the first half was up 8.3% year on year to GBP175.8 million from GBP162.3 million.

----------

Future PLC, up 11%. The publisher's acquisition of TI Media will complete shortly, following the announcement by the UK competition watchdog that it has accepted Future's undertakings and will end its investigation of the merger. Future had announced the GBP140 million purchase of fellow magazine publisher TI Media last October. The UK Competition & Markets Authority, however, raised concerns in January but later said it would pass the acquisition if Future agreed to sell three competing titles. In late March, Future confirmed it has agreed to sell WorldSoccer, Amateur Photographer, and Trustedreviews.com. All are in an advanced stage of talks with potential buyers. After which, the CMA said those remedies meant the regulator now believes there are reasonable grounds to approve the acquisition.

----------

Man Group, up 4.6%. The asset manager saw its assets under management fall amid the market decline caused by the virus pandemic. Despite the fall in funds, Man Group said its balance sheet and liquidity remains "robust". As a result, it intends to proceed with its dividend distribution and continue with its share buyback as planned. At March 31, Man Group's FuM stood at USD104.2 billion, down 11% from USD117.7 billion at the end of 2019. While Man Group was able to record USD500 million in net inflows in the quarter, market movements shaved USD10.7 billion off funds. Foreign exchange movements subtracted a further GBP3.3 billion.

----------

FTSE 250 - LOSERS

----------

Mediclininc International, down 2.5%. The company's trading for its recently-ended financial year was in line with expectations, though it has suspended its dividend in order to support liquidity in the face of Covid-19. On a reported basis, revenue for the financial year ended March is expected to grow 5.5%, while pre-IFRS 16 Ebitda is set to fall 2.5%. At constant currency, revenue was up 4.0% and Ebitda down 3.5%. As at the end of March, Mediclinic had "material" headroom to covenants in its existing debt facilities as well as a strong liquidity position. Cash and available facilities at the year-end stood around GBP515 million. To further support the group's liquidity position, all non-urgent and non-committed capital programmes have been postponed - including suspending its dividend.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Foxtons, up 12%. The estate agent will raise GBP22.0 million in new capital to avert a liquidity crisis in the event the UK government-imposed lockdown lasts until the end of August and is followed by a slow recovery in London housing market. Foxtons plans to issue up to 54.9 million new shares at 40p per share to raise GBP22 million. The placing price represents a premium of 4.2% to 38.4p share price on Thursday. Foxtons recorded a dip in first-quarter revenue as the UK government lockdown measures impacted trading for the final two weeks of March. The company, however, saw strong and steady growth in sales commission pipeline during the first two months of 2020. Revenue for the three months to March-end fell 3% to GBP23.0 million from GBP23.8 million a year ago. Lettings revenue fell 5% to GBP13.9 million, sales revenue was flat at GBP7.1 million and mortgage broking revenue was down 5% to GBP1.9 million.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

NetScientific, down 26%. The firm's portfolio company PDS Biotechnology Corp has initiated a vaccine development program for Covid-19 and universal influenza. Shares in NetScientific more than doubled following the news on Thursday but have pulled back on Friday. The company owns around a 7% stake in PDS Biotechnology. The UK-listed healthcare intellectual property commercialisation company also said that PDS Biotechnology has delayed its phase 2 trial for PDS0101 in advanced metastatic head and neck cancer due to the impact on clinical trial operations from the Covid-19 pandemic.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
15 Apr 2024 11:06

NetScientific investee secures funding to develop product range

(Alliance News) - NetScientific PLC on Monday said its portfolio company ProAxsis Ltd secured GBP1.8 million in investment.

Read more
27 Mar 2024 18:47

TRADING UPDATES: Empire Metals targets key milestones in Australia

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
13 Mar 2024 17:04

NetScientific "significantly" advances strategic goals

(Alliance News) - NetScientific PLC on Wednesday released a portfolio and strategy update.

Read more
23 Jan 2024 18:39

TRADING UPDATES: Esken's Southend Airport faces further allegations

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
1 Dec 2023 11:59

IN BRIEF: NetScientific investee DeepTech Recycling bags GBP1 million

NetScientific PLC - technology and life sciences investor - Portfolio company DeepTech Recycling Ltd closes GBP1 million fundraising. DeepTech, in which NetScientific holds a 30% stake, is a company focused on chemical recycling of plastic waste. Last December, it bought the assets of Recycling Technologies Ltd out of administration. The fundraise is carried out via an advance share subscription agreement and is the first closing of a target investment programme of around GBP3 million, with further investment anticipated within the next six months.

Read more
9 Nov 2023 19:41

IN BRIEF: NetScientific's portfolio company updates on cancer trial

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investor -

Read more
6 Nov 2023 12:00

IN BRIEF: NetScientific says Ventive on fire with new investment

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investor - Says portfolio company Ventive, a London-based designer and manufacturer of heating and ventillation solutions, has successfuly closed a new investment of around GBP900,000. Funding included GBP316,000 from existing shareholders and the conversion of two existing convertible loans valued at about GBP600,000. Investment is part of Ventive's proposed GBP1 million to GBP1.5 million programme, with further investments expected by April 30. NetScientific now holds an 11% total equity stake in Ventive, with a post-investment fair value of GBP893,000 - up from GBP52,000 at December 31.

Read more
23 Oct 2023 21:10

NetScientific investee claims promising results in biomarker study

(Alliance News) - NetScientific PLC on Monday said its investee PDS Biotechnology Corp was "encouraged" by study data for its PDS0101 combined with Merck & Co Inc's drug Keytruda.

Read more
3 Oct 2023 17:12

IN BRIEF: NetScientific portfolio company updates on cancer trial

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investment company - Reports that its portfolio company, PDS Biotechnology Corp, has announced updated interim data from the Versatile-002 phase two clinical trial evaluating PDS0101 in combination with Merck & Co Inc's Keytruda in patients with unresectable, recurrent, or metastatic HPV16-positive head and neck squamous cell carcinoma.

Read more
28 Sep 2023 14:24

EARNINGS: Dar Global profit multiplies, Hemogenyx loss widens

(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
13 Sep 2023 21:32

NetScientific's Q-Bot completes GBP3.5 million investment programme

(Alliance News) - NetScientific PLC on Wednesday said that its portfolio company, Q-Bot, has successfully closed a GBP3.5 million investment programme.

Read more
14 Aug 2023 19:49

IN BRIEF: NetScientific's PDS suffers wider loss as R&D costs mount

NetScientific PLC - London-based investment firm focused on life science, sustainability and technology companies - Portfolio company PDS Biotechnology Corp reports results for the quarter to June 30. Net loss was USD11.5 million, widened from USD5.8 million the year before. Higher loss primarily due to costs incurred in connection with research and development programmes, which more than doubled to USD8.0 million from USD3.8 million. Loss per share of USD0.37 compared to USD0.20 before. Further, PDS reports the successful submission of final clinical protocol and supporting information to the US Food & Drug Administration to initiate phase 3 Versatile-003 trial in the fourth quarter. Adds biomarker data from Versatile-002 will be presented at the European Society for Medical Oncology Congress.

Read more
30 Jun 2023 14:07

TRADING UPDATES: Pendragon quarterly trading momentum maintained

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
29 Jun 2023 14:11

TRADING UPDATES: tinyBuild bemoans disappointing interim performance

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
22 Jun 2023 17:15

IN BRIEF: NetScientific investee Vortex nabs six-figure investment

NetScientific PLC - London-based investment firm focused on life science, sustainability and technology companies - Announces completion of new GBP3.2 million investment round in portfolio company Vortex Biotech Holdings Ltd, led by EMV Capital. NetScientific converted its GBP400,000 loan into equity alongside new Vortex investors. NetScientific now has a 24.98% total equity holding in Vortex. This equates to a post-investment fair value of GBP2.8 million, quadruple the GBP700,000 value reported at December 31.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.